Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells

被引:18
作者
Fischer, W
Metzner, L
Hoffmann, K
Neubert, RHH
Brandsch, M
机构
[1] Univ Halle Wittenberg, Biozentrum, Membrane Transport Grp, D-06120 Halle, Germany
[2] Univ Halle Wittenberg, Dept Pharm, Inst Pharmaceut & Biopharmaceut, D-06120 Halle, Germany
关键词
Caco-2; cells; clonidine-derived drugs; drug delivery; membrane transport;
D O I
10.1007/s11095-005-8925-x
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Purpose. This study was performed to characterize the Substrate specificity and mechanism of the intestinal clonidine transport. Methods. Uptake of [H-3]clonidine into Caco-2 cells was investigated. Interaction with drug was studied in competition assays. Results. Uptake of [H-3]clonidine was linear for up to 2 min, Na+-independent, and insensitive to changes in membrane potential, but strongly H+-dependent. The uptake rate of clonidine was saturable with kinetic parameters of 0.5 +/- 0.1 mM (K-t) and 16.6 +/- 1.8 nmol/2 min per mg of protein (V-max) at an outside pH of 7.5. Many drugs such as clonidine, guanabenz. methamphetamine, imipramine, clomipramine, nortriptyline, quinine, xylazine, ephedrine, and diphenhydramine strongly, inhibited the [H-3]clonidine uptake with K-i values between 0.15 and 1 mM. Conclusions. Clonidine is transported by a carrier-mediated process. Substrate specificity and mechanism are very similar to the transport described in blood-brain barrier endothelial cells. The transport characteristics do not correspond to carriers for organic cations of the SLC22 family or the choline transporters CHT1 and CLT1. The system might be identical to the H+/tertiary amine antiporter. It interacts with a large number of both hydrophilic and lipophilic cationic drugs, and also interestingly, with opiates.
引用
收藏
页码:131 / 137
页数:7
相关论文
共 27 条
[1]
The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [J].
Barendt, WM ;
Wright, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22491-22496
[2]
Mutational and pH analysis of ionic residues in transmembrane domains of vesicular acetylcholine transporter [J].
Bravo, DT ;
Kolmakova, NG ;
Parsons, SM .
BIOCHEMISTRY, 2005, 44 (22) :7955-7966
[3]
Intestinal transport of β-lactam antibiotics:: Analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux [J].
Bretschneider, B ;
Brandsch, M ;
Neubert, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (01) :55-61
[4]
A MODEL OF HUMAN SMALL INTESTINAL ABSORPTIVE CELLS .1. TRANSPORT BARRIER [J].
COGBURN, JN ;
DONOVAN, MG ;
SCHASTEEN, CS .
PHARMACEUTICAL RESEARCH, 1991, 8 (02) :210-216
[5]
DEMONSTRATION AND MODIFICATION OF INTERVILLOUS PH PROFILES IN RAT SMALL-INTESTINE INVITRO [J].
DANIEL, H ;
FETT, C ;
KRATZ, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (04) :G489-G495
[6]
A novel high-throughput PepT1 transporter assay differentiates between substrates and antagonists [J].
Faria, Teresa N. ;
Timoszyk, Julita K. ;
Stouch, Terry R. ;
Vig, Balvinder S. ;
Landowski, Christopher P. ;
Amidon, Gordon L. ;
Weaver, C. David ;
Wall, Doris A. ;
Smith, Ronald L. .
MOLECULAR PHARMACEUTICS, 2004, 1 (01) :67-76
[7]
Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4) [J].
Friedrich, A ;
George, RL ;
Bridges, CC ;
Prasad, PD ;
Ganapathy, V .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1512 (02) :299-307
[8]
CLONIDINE KINETICS IN MAN - EVIDENCE FOR DOSE DEPENDENCY AND CHANGED PHARMACOKINETICS DURING CHRONIC THERAPY [J].
FRISKHOLMBERG, M ;
PAALZOW, L ;
EDLUND, PO .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (05) :653-658
[9]
INTERACTION OF CLONIDINE WITH HUMAN PLACENTAL NA+-H+ EXCHANGER [J].
GANAPATHY, ME ;
LEIBACH, FH ;
MAHESH, VB ;
DEVOE, LD ;
GANAPATHY, V .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (22) :3989-3994
[10]
Carrier-mediated transport of clonidine in human keratinocytes [J].
Grafe, F ;
Wohlrab, W ;
Neubert, R ;
Brandsch, M .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (2-3) :309-312